ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
6.63
+0.09 (1.38%)
Feb 19, 2026, 4:00 PM EST - Market closed

ImageneBio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023
Period Ending
Feb '26 Dec '24 Dec '23
Debt / Equity Ratio
0.03-5.270.05
Net Debt / Equity Ratio
-0.992.67-1.16
Net Debt / EBITDA Ratio
3.020.111.25
Net Debt / FCF Ratio
3.160.191.32
Asset Turnover
-0.15-
Quick Ratio
12.860.712.71
Current Ratio
13.240.732.73
Return on Equity (ROE)
--373.35%-
Return on Assets (ROA)
--98.06%-
Return on Capital Employed (ROCE)
-30.80%2874.90%-100.80%
Buyback Yield / Dilution
-22.59%-21.97%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q